Pulmonary Emphysema: Current Understanding of Disease Pathogenesis and Therapeutic Approaches
Open Access
- 30 August 2025
- journal article
- review article
- Published by MDPI AG in Biomedicines
- Vol. 13 (9) , 2120
Abstract
Pulmonary emphysema, the main component of chronic obstructive pulmonary disease, is a chronic lung inflammatory disease characterized by the loss of lung elasticity and impaired gas exchange due in large part to the destruction of alveolar walls. Cigarette smoking represents the most frequent etiologic factor, but other factors involving environmental pollution and respiratory infections contribute to disease pathogenesis and worsening. In this review, we provide a review about emphysema covering risk factors; underlying mechanisms of disease pathogenesis; experimental models that mimic, as closely as possible, human disease features; and available therapeutics. Lastly, exploratory therapeutic approaches aimed at improving patient health through evidence-based and personalized medicine are presented as well.Keywords
This publication has 234 references indexed in Scilit:
- Prediction of disease severity in COPD: a deep learning approach for anomaly-based quantitative assessment of chest CTEuropean Radiology, 2023
- Remodeling of the Aged and Emphysematous Lungs: Roles of Microenvironmental CuesComprehensive Physiology, 2022
- The role of miRNAs in alveolar epithelial cells in emphysemaBiomedicine & Pharmacotherapy, 2021
- Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary diseaseCochrane Database of Systematic Reviews, 2017
- Informe 2017 de la Iniciativa Global para el Diagnóstico, Tratamiento y Prevención de la Enfermedad Pulmonar Obstructiva Crónica: Resumen Ejecutivo de GOLDArchivos de Bronconeumología, 2017
- Neutrophil elastase inhibitors for the treatment of (cardio)pulmonary diseases: Into clinical testing with pre-adaptive pharmacophoresBioorganic & Medicinal Chemistry Letters, 2015
- Unopposed Cathepsin G, Neutrophil Elastase, and Proteinase 3 Cause Severe Lung Damage and EmphysemaThe American Journal of Pathology, 2014
- Dry powders for oral inhalation free of lactose carrier particlesAdvanced Drug Delivery Reviews, 2014
- Targeting COPD: advances on low‐molecular‐weight inhibitors of human neutrophil elastaseMedicinal Research Reviews, 2011
- Development of highly porous large PLGA microparticles for pulmonary drug deliveryBiomaterials, 2009